PinkDx Raises $40M in Series A Funding led by Catalio Capital Management, LP and The Production Board

Apr 25, 2024•over 1 year ago

Amount Raised

$40 Million

Round Type

series a

Daly CityBiotechnology

Investors

Mayo ClinicByers CapitalMountain Group PartnersThe Production BoardCatalio Capital Management, Lp

Description

PinkDx, Inc., a Daly City, CA-based company, raised $40m in Series A financing. The round was co-led by Catalio Capital Management, LP, and The Production Board, with other investors including Mountain Group Partners, Byers Capital, and Mayo Clinic. The company will use the funds to test development, focusing initially on gynecological cancers.

Company Information

Company

PinkDx

Location

2001 Junipero Serra Blvd., Suite 610

Daly City, California, United States

About

PinkDx is an early-stage company focused on addressing the medical problems that women uniquely face by applying sophisticated scientific approaches to resolve them and providing answers that have an immediate, positive impact on their lives. The company's first indication will focus on overcoming diagnostic challenges for women who present with general symptoms that could signal a gynecological cancer.

Related People

4 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends